BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

10 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Click chemistry inspired one-pot synthesis of 1,4-disubstituted 1,2,3-triazoles and their Src kinase inhibitory activity.EBI
Institute of Technology and Science
Recent progress toward developing axial chirality bioactive compounds.EBI
Shandong University
Isoquinolin-3-yl carboxamides and preparation and use thereofBDB
Samumed
Substituted amino triazoles useful as human chitinase inhibitorsBDB
Oncoarendi Therapeutics
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitorsBDB
Oryzon Genomics
Use of pyrazolopyrimidine derivatives for the treatment of PI3K-delta related disordersBDB
Incyte
N-aryl-oxazolidin-2-imine muscle selective androgen receptor modulators enhance potency through pharmacophore reorientation.BDB
Bristol-Myers Squibb
Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug design.BDB
Boehringer Ingelheim Pharmaceuticals
Second generation of hydroxyethylamine BACE-1 inhibitors: optimizing potency and oral bioavailability.BDB
Gsk